22.728 articles found

Norepinephrine: the next therapeutics frontier for Parkinson's disease.

Lewitt PA.

Transl Neurodegener · 2012-01-13

DOI: 10.1186/2047-9158-1-4PMID: 23211006

Neurorestoration therapeutics for neurodegenerative and psychiatric disease.

Bednar MM, Perry A.

Neurol Res · 2012-01-13

DOI: 10.1179/1743132811y.0000000069PMID: 22333068

Is freezing of gait in Parkinson's disease a result of multiple gait impairments? Implications for treatment.

Plotnik M, Giladi N, Hausdorff JM.

Parkinsons Dis · 2012-01-12

DOI: 10.1155/2012/459321PMID: 22288021

New pharmacological avenues for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors.

Blandini F, Armentero MT.

Expert Opin Investig Drugs · 2012-01-11

DOI: 10.1517/13543784.2012.651457PMID: 22233485

Efficacy and safety of deep brain stimulation as an adjunct to pharmacotherapy for the treatment of Parkinson disease.

Sharma A, Szeto K, Desilets AR.

Ann Pharmacother · 2012-01-10

DOI: 10.1345/aph.1q508PMID: 22234991

Dopaminergic neurons for Parkinson's therapy.

Lindvall O.

Nat Biotechnol · 2012-01-09

DOI: 10.1038/nbt.2077PMID: 22231097

Selective IGT decision-making impairment in a patient with juvenile Parkinson's disease and pathological gambling: a role for dopaminergic therapy?

Pignatti R, Brioschi A, Mauro A, Zamarian L, Wenter J, Semenza C.

Neurocase · 2012-01-06

DOI: 10.1080/13554794.2011.633529PMID: 22224448

Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.

Navailles S, De Deurwaerdère P.

Mol Neurobiol · 2012-01-06

DOI: 10.1007/s12035-011-8230-0PMID: 22222679

Clinical application of stem cell therapy in Parkinson's disease.

Politis M, Lindvall O.

BMC Med · 2012-01-04

DOI: 10.1186/1741-7015-10-1PMID: 22216957

Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson's disease.

Gershanik O, Jenner P.

Eur J Neurol · 2012-01-04

DOI: 10.1111/j.1468-1331.2011.03593.xPMID: 22221452

A METHOD OF TREATMENT OF A NEUROLOGICAL DISORDER.

VIEIRA MICHAEL L, BRYAN JONES WOODROW JR.

· 2012-01-02

Selenite benefits embryonic stem cells therapy in the animal models of Parkinson’s disease through inhibiting inflammation

Tian L, Zhang S, Xu L, Li W, Wang Y, Chen W, Ding J, Chen S.

Molecular neurodegeneration · 2012-01-01

DOI: 10.1186/1750-1326-7-s1-l25